Aryx Therapeutics I Price on November 26, 2024

ARYXDelisted Stock  USD 0.0005  0.00  0.00%   
If you're considering investing in Aryx Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Aryx Therapeutics stands at 0.0005, as last reported on the 14th of December 2024, with the highest price reaching 0.0005 and the lowest price hitting 0.0005 during the day. We have found three technical indicators for Aryx Therapeutics I, which you can use to evaluate the volatility of the firm.
  
Aryx Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
ARYX
Based on monthly moving average Aryx Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aryx Therapeutics by adding Aryx Therapeutics to a well-diversified portfolio.

Related Headline

Phibro Animal Headline on 26th of November 2024

Whether youre a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Aryx Therapeutics Valuation on November 26, 2024

It is possible to determine the worth of Aryx Therapeutics on a given historical date. On November 26, 2024 Aryx was worth 5.0E-4 at the beginning of the trading date compared to the closed value of 5.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Aryx Therapeutics pink sheet. Still, in general, we apply an absolute valuation method to find Aryx Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aryx Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Aryx Therapeutics' related companies.
 Open High Low Close Volume
12/14/2024
  0.0005    0.0005    0.0005    0.0005    0.00  
Backtest Aryx Therapeutics  |  Aryx Therapeutics History  |  Aryx Therapeutics Valuation 
Open Value
5.0E-4
5.0E-4
Closing Value
0.00
Upside

Aryx Therapeutics Trading Date Momentum on November 26, 2024

Aryx Therapeutics Fundamentals Correlations and Trends

By evaluating Aryx Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Aryx Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Aryx financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Aryx Therapeutics Pink Sheet history

Aryx Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aryx is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aryx Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aryx Therapeutics stock prices may prove useful in developing a viable investing in Aryx Therapeutics
ARYx Therapeutics, Inc. discovers and develops novel therapies for large, chronic, and oral markets. ARYx Therapeutics, Inc. was founded in 1997 and is based in Fremont, California. ARYX THERAPEUTICS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on PNK Exchange. It employs 56 people.

Aryx Therapeutics Pink Sheet Technical Analysis

Aryx Therapeutics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Aryx Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Aryx Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Aryx Therapeutics Period Price Range

Low
December 14, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Aryx Therapeutics I cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Aryx Therapeutics December 14, 2024 Market Strength

Market strength indicators help investors to evaluate how Aryx Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aryx Therapeutics shares will generate the highest return on investment. By undertsting and applying Aryx Therapeutics pink sheet market strength indicators, traders can identify Aryx Therapeutics I entry and exit signals to maximize returns
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Consideration for investing in Aryx Pink Sheet

If you are still planning to invest in Aryx Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aryx Therapeutics' history and understand the potential risks before investing.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets